Śpiewak, D.; Drzyzga, Ł.; Dorecka, M.; Witek, K.; Wyględowska-Promieńska, D.
Efficacy of Faricimab in the Treatment of Diabetic Macular Edema and Faricimab-Related Changes in OCT and OCT Angiography. Pharmaceutics 2025, 17, 858.
https://doi.org/10.3390/pharmaceutics17070858
AMA Style
Śpiewak D, Drzyzga Ł, Dorecka M, Witek K, Wyględowska-Promieńska D.
Efficacy of Faricimab in the Treatment of Diabetic Macular Edema and Faricimab-Related Changes in OCT and OCT Angiography. Pharmaceutics. 2025; 17(7):858.
https://doi.org/10.3390/pharmaceutics17070858
Chicago/Turabian Style
Śpiewak, Dorota, Łukasz Drzyzga, Mariola Dorecka, Katarzyna Witek, and Dorota Wyględowska-Promieńska.
2025. "Efficacy of Faricimab in the Treatment of Diabetic Macular Edema and Faricimab-Related Changes in OCT and OCT Angiography" Pharmaceutics 17, no. 7: 858.
https://doi.org/10.3390/pharmaceutics17070858
APA Style
Śpiewak, D., Drzyzga, Ł., Dorecka, M., Witek, K., & Wyględowska-Promieńska, D.
(2025). Efficacy of Faricimab in the Treatment of Diabetic Macular Edema and Faricimab-Related Changes in OCT and OCT Angiography. Pharmaceutics, 17(7), 858.
https://doi.org/10.3390/pharmaceutics17070858